JST top page
ICORP International Cooperative Research Project  JST Basic Research Program/ICORP Type
to Japanese page English page
ICORP top page The Outline of ICORP On-going Projects Past Projects
ICORP top page > Past Projects > Development of HIV/AIDS vaccine for HIV-1 Subtype-E Project
Past Projects
Ultrashort Pulse Laser
Membrane Mechanisms
Quantum Spin Information
Organ Regeneration
Computational Brain
Nanoscale Quantum Conductor Array
Dynamic Nanomachine
Entropy Control
Calcium Oscillation
Photon Craft
Cell Mechanosensing
Quantum Entanglement
Development of HIV/AIDS vaccine for HIV-1 Subtype-E
Single Molecule Processes
Cold Trapped Ion
Mind Articulation
Ceramics Superplasticity
Quantum Transition
Subfemtomole Biorecognition
Microbial Evolution
Atom Arrangement-Design and Control for New Materials
1998.3~2003.3 Development of HIV/AIDS vaccine for HIV-1 Subtype-E Project
Research Directors
Dr. Mitsuo Honda Dr. Mitsuo Honda
Group Leader at AIDS Research Center, National Institute of Infectious Diseases
Dr. Paijit Warachit   Dr. Paijit Warachit
Director-General of Department of Medical Sciences, Ministry of Public Health, Thailand

Counterpart Organization: Ministry of Public Health (Thailand)
Supporting National Agency: National Research Council of Thailand

AIDS is a virus-infectious disease caused by human immunodeficiency virus (HIV) infection. HIV is roughly divided into types A to K according to structural differences in viral genes. Paying attention to the fact that the BCG vaccine,the recombinant of HIV antigen secretion type,induces cellular or liquid immunities specifically for HIV, we searched for possibilities of developing Clade E-type viral vaccine with the BCG as a vector through the collaborative research with Thailand.
We did experiments mainly on animals using monkeys about the applicability of administering the vaccine, its safety and its stability. Our findings were valued by experts of the World Health Organization (WHO), the Center for Disease Control and Prevention (CDC), etc. The next step for the vaccine,a clinical trial for humans,were brought into considerations.
Japan Science and Technology Agency
JST top page